m-PEG7-Ms structure
|
Common Name | m-PEG7-Ms | ||
|---|---|---|---|---|
| CAS Number | 477775-57-8 | Molecular Weight | 418.50000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H34O10S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of m-PEG7-Msm-PEG7-Ms is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. |
| Name | 20-methoxy-1-(methylsulfonyl)oxy-3,6,9,12,15,18-hexaoxaeicosane |
|---|---|
| Synonym | More Synonyms |
| Description | m-PEG7-Ms is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. |
|---|---|
| Related Catalog | |
| Target |
Cleavable |
| In Vitro | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. |
| References |
[1]. Sanxing Sun, et al. Triazolotriazine derivatives as a2a receptor antagonists. WO2020002969A1. |
| Molecular Formula | C16H34O10S |
|---|---|
| Molecular Weight | 418.50000 |
| Exact Mass | 418.18700 |
| PSA | 116.36000 |
| LogP | 0.78940 |
| Hazard Codes | Xi |
|---|
| 20-methoxy-(methylsulfonyl)oxy-3,6,9,12,15,18-hexaoxaeicosane |
| polyethyleneglycol-350 monomethylether methanesulfonate |
| 20-methoxy--(methylsulfonyl)oxy-3,6,9,12,15,18-hexaoxaeicosane |
| Methanesulfonic acid 2-{2-[2-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethyl ester |
| 2,5,8,11,14,17,20-heptaoxadocosan-22-yl methanesulfonate |
| mPEG7-OMs |